PubMed list
of Jörg Schulzke, |
2024
Heimesaat MM, Mousavi S, Lobo de Sá FD, Peh E, Schulzke JD, Bücker R, Kittler S, Bereswill S (2024) Oral curcumin ameliorates acute murine campylobacteriosis. Front Immunol. 15: 1363457 (14 pages). doi: 10.3389/fimmu.2024.1363457 (°IF 5.7)
Consortial collaborations
Horn V, Cancino CA, Steinheuer LM, Obermayer B, Fritz K, Nguyen AL, Juhran KS, Plattner C, Bösel D, Oldenburg L, Burns M, Schulz AR, Saliutina M, Mantzivi E, Lissner D, Conrad T, Mashreghi MF, Zundler S, Sonnenberg E, Schumann M, Haag LM, Beule D, Flatz L, TRR241 IBDome Consortium* (*with Schulzke JD), Trjanoski Z, D'Haens G, Weidinger C, Mei HE, Siegmund B, Thurley K, Hegazy AN (2024) Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4+ T cells as predictors for response to integrin α4β7-blocking therapy in inflammatory bowel disease.
Erkert L, Gamez-Belmonte R, Kabisch M, Schödel L, Patankar JV, Gonzalez-Acera M, Mahapatro M, Bao LL, Plattner C, Kühl AA, Shen J, Serneels L, De Strooper B; TRR241 IBDome Consortium* (*with Schulzke JD); Neurath MF, Wirtz S, Becker C (2024) Alzheimer's disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis. Gut 73(10): 1618-1631. doi: 10.1136/gutjnl-2023-331622 (°IF 23.0)
Lehmann M, Weixler B, Elezkurtaj S, Loddenkemper C, TRR241 IBDome Consortium* (*with Schulzke JD), Kühl AA, Siegmund B (2024) Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn's Disease.
Schulz-Kuhnt A, Rühle K, Javidmehr A, Döbrönti M, Biwank J, Knittel S, Neidlinger P, Leupold J, Liu LJ, Dedden M, Taudte RV, Gessner A, Fromm MF, Mielenz D, Kreiss L, Waldner MJ, Schürmann S, Friedrich O, Dietel B, López-Posadas R, Plattner C, TRR241 IBDome Consortium* (*with Schulzke JD), Zundler S, Becker C, Atreya R, Neurath MF, Atreya I (2024) ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo. Gut 73(4): 601-612. doi: 10.1136/gutjnl-2023-330543 (°IF 23.0)
2023
Awad K, Barmeyer C, Bojarski C, Nagel O, Lee IM, Schweiger MR, Schulzke JD*, Bücker R* (*shared last authorship) (2023) Epithelial barrier dysfunction in diarrhea-predominant irritable bowel syndrome (IBS-D) via downregulation of claudin-1. Cells 12(24), 2846 (17 pages). doi: 10.3390/cells12242846 (IF 5.1)
Awad K, Barmeyer C, Bojarski C, Nagel O, Lee IM, Schweiger MR, Schulzke JD*, Bücker R* (*shared last authorship) (2023) Impaired intestinal permeability of tricellular tight junctions in patients with irritable bowel syndrome with mixed bowel habits (IBS-M). Cells 12(2), 236 (19 pages); doi: 10.3390/cells12020236, Supplement (IF 5.1)
Friebel J, Schinnerling K, Weigt K, Heldt C, Fromm A, Bojarski C, Siegmund B, Epple HJ, Kikhney J, Moter A, Schneider T, Schulzke JD, Moos V, Schumann M (2023) Uptake of Tropheryma whipplei by intestinal epithelia. Int. J. Mol. Sci. 24(7): 6197 (20 pages) doi: 10.3390/ijms24076197 (IF 4.9)
Hader H, Hering NA, Schulzke JD, Bücker R, Rosenthal R (2023) Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells. Front. Pharmacol. 14: 1301800 (11 pages). doi: 10.3389/fphar.2023.1301800 (IF 4.4)
Heils L, Schneemann M, Gerhard R, Schulzke JD, Bücker R (2023) CDT of Clostridioides difficile induces MLC-dependent intestinal barrier dysfunction in HT-29/B6 epithelial cell monolayers. Toxins (Basel) 15(1): 54 (15 pages). doi: 10.3390/toxins15010054 (IF 3.9)
Krug SM, Grünhagen C, Allers K, Bojarski C, Seybold J, Schneider T, Schulzke JD, Epple HJ (2023) Macromolecule translocation across the intestinal mucosa of HIV-infected patients by transcytosis and through apoptotic leaks. Cells 12(14): 1887 (13 pages). doi: 10.3390/cells12141887 (IF 5.1)
Omarova S, Awad K, Moos V, Püning C, Gölz G, Schulzke JD, Bücker R (2023) Intestinal barrier in post-Campylobacter jejuni irritable bowel syndrome. Biomolecules 13(3): 449 (14 pages). doi: 10.3390/biom13030449 (IF 4.8)
Schneemann M, Heils L, Moos V, Weiß F, Krug SM, Weiner J, Beule D, Gerhard R, Schulzke JD, Bücker R (2023) A colonic organoid model challenged with the large toxins of Clostridioides difficile TcdA and TcdB exhibit deregulated tight junction proteins. Toxins 15: 643 (19 pages). doi: 10.3390/toxins15110643 (IF 3.9)
2022
Holthaus D*, Kraft MR* (*shared first authorship), Krug SM, Wolf S, Müller A, Delgado Betancourt E, Schorr M, Holland G, Knauf F, Schulzke JD, Aebischer T°, Klotz C° (°shared last authorship) (2022) Dissection of barrier dysfunction in organoid-derived human intestinal epithelia induced by Giardia duodenalis. Gastroenterology 162(3): 844-858, doi.org/10.1053/j.gastro.2021.11.022 (IF 29.4)
Kaak JL, Lobo de Sá FD, Turner JR, Schulzke JD, Bücker R (2022) Unraveling the intestinal epithelial barrier in cyanotoxin microcystin-treated Caco-2 cell monolayers. Ann. NY Acad. Sci. 1516(1): 188-196, doi: 10.1111/nyas.14870 (IF 5.2)
Warschkau D, Delgado-Betancourt E, Holthaus D, Müller A, Kliem G, Krug SM, Schulzke JD, Aebischer T, Klotz C*, Seeber F* (*shared last authorship) (2022). From 3D to 2D: Harmonization of protocols for two-dimensional cultures on cell culture inserts of intestinal organoids from various species. Bio-protocol 12(2): e4295 (25 pages). doi: 10.21769/BioProtoc.4295
Weiß F, Holthaus D, Kraft M, Klotz C, Schneemann M, Schulzke JD, Krug SM (2022) Human duodenal organoid derived monolayers serve as a suitable barrier model for duodenal tissue. Ann. NY Acad. Sci. 1515(1): 155-167, doi: 10.111/nyas.14804 (IF 5.2)
Zejc T, Piontek J, Schulzke JD, Fromm M, Ervens J*, Rosenthal R* (*shared last authorship) (2022) Clinical significance of claudin expression in oral squamous cell carcinoma. Int. J. Mol. Sci. 23(19): 11234 (13 pages), doi: 10.3390/ijms231911234 (IF 5.6)
2021
Hering NA, Luettig J, Jebautzke B, Schulzke JD, Rosenthal R (2021) The punicalagin metabolites ellagic acid and urolithin A exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro. Front. Pharmacol. 12: 610164, doi: 10.3389/fphar.2021.610164 (IF 6.0)
Hu JCE, Weiß F, Bojarski C, Branchi F, Schulzke JD, Fromm M, Krug SM (2021) Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterology 21(1): 141, doi: 10.1186/s12876-021-01723-7 (IF 2.9)
Lobo de Sá FD, Backert S, Nattramilarasu PK, Mousavi S, Sandle GI, Bereswill S, Heimesaat MM, Schulzke JD, Bücker R (2021) Vitamin D reverses disruption of gut epithelial barrier function caused by Campylobacter jejuni. Int. J. Mol. Sci. 22(16): 8872 (16 pages). doi: 10.3390/ijms22168872 (IF 6.2)
Lobo de Sá FD, Heimesaat MM, Bereswill S, Nattramilarasu PK, Schulzke JD, Bücker R (2021) Resveratrol prevents Campylobacter jejuni-induced leaky gut by restoring occludin and claudin-5 in the paracellular leak pathway. Front. Pharmacol. 12: 640572. doi: 10.3389/fphar.2021.640572 (IF 6.0)
Lobo de Sá FD, Schulzke JD, Bücker R (2021) Diarrheal mechanisms and the role of intestinal barrier dysfunction in Campylobacter infections. Curr. Top. Microbiol. Immunol. 431: 203-231. doi: 10.1007/978-3-030-65481-8_8 (IF 4.7)
Nattramilarasu PK, Lobo de Sá FD, Schulzke JD, Bücker R (2021) Immune-mediated aggravation of the Campylobacter concisus-induced epithelial barrier dysfunction. Int. J. Mol. Sci. 22(4): 2043 (23 pages). doi: 10.3390/ijms22042043, Supplement PDF (IF 6.2)
Schulz E, Schumann M, Schneemann M, Dony V, Fromm A, Nagel O, Schulzke JD, Bücker R (2021) Escherichia coli alpha-hemolysin HlyA induces host cell polarity changes, epithelial barrier dysfunction and cell detachment in human colon carcinoma Caco-2 cell model via PTEN-dependent dysregulation of cell junctions. Toxins 13(8): 520 (22 pages). doi: 10.3390/toxins13080520. (IF 5.1)
2020
Heimesaat MM, Mousavi S, Escher U, Lobo de Sá FD, Peh E, Schulzke JD, Kittler S, Bücker R, Bereswill S (2020) Resveratrol alleviates acute Campylobacter jejuni-induced enterocolitis in a preclinical murine intervention study. Microorganisms 8: 1858 (15 pages) (IF 4.1) [PubMed] [DOI] [PDF] [Supplement]
Bücker R, Zakrzewski SS, Wiegand S, Pieper R, Fromm A, Fromm M, Günzel D, Schulzke JD (2020) Zinc prevents intestinal epithelial barrier dysfunction induced by alpha-hemolysin-producing Escherichia coli 536 infection in porcine colon. Vet. Microbiol. 243: 108632 (6 pages) [PubMed] [WebPage] [PDF] [Supplement] (IF 3.3)
Nattramilarasu PK, Bücker R, Lobo de Sá FD, Fromm A, Nagel O, Lee IM, Butkevych E, Mousavi S, Genger C, Kløve S, Heimesaat MM, Bereswill S, Schweiger MR, Nielsen HL, Troeger H, Schulzke JD (2020) Campylobacter concisus impairs sodium absorption in colonic epithelium via ENaC dysfunction and claudin-8 disruption. Int. J. Mol. Sci. 21(2): e373 (23 pages) (IF 5.9) [PubMed] [WebPage] [PDF] [Supplements]
Kjærgaard S, Damm MMB, Chang J, Riis LB, Rasmussen HB, Hytting-Andreasen R, Krug SM, Schulzke JD, Bindslev N, Berner-Hansen M (2020) Altered structural expression and enzymatic activity parameters in quiescent ulcerative colitis: Are these potential normalization criteria? Int. J. Mol. Sci. 21(5): e1887 (18 pages) (IF 5.9) [PubMed] [WebPage] [PDF]
Book chapter
Schulzke JD, Fromm M (2020) Chapter 3: Role of the epithelium in diseases of the intestine, in: Ion transport across epithelial tissues and disease, Vol. 2: Ion channels and transporters of epithelia in health and disease. p 77-109. In: Hamilton KL, Devor DC (eds.), 2. edn., Springer / Am. Physiol. Soc. [DOI] [PDF whole book] [Amazon] [Springer]
2019
Ayala-Torres C, Krug SM, Schulzke JD, Rosenthal R*, Fromm M* (*shared last authorship) (2019) Tricellulin effect on paracellular water transport. Int. J. Mol. Sci. 20(22): 5700 (15 pages) (IF 4.6) [PubMed] [WebPage] [PDF]
Hering NA, Fromm A, Bücker R, Gorkiewicz G, Zechner EL, Högenauer C, Fromm M, Schulzke JD, Troeger H (2019) Tilivalline- and tilimycin-independent effects of Klebsiella oxytoca on tight junction-mediated intestinal barrier impairment. Int. J. Mol. Sci. 20(22): 5595 (16 pages) (IF 4.6) [PubMed] [WebPage] [PDF]
Lobo de Sá FD, Butkevych E, Nattramilarasu PK, Fromm A, Mousavi S, Moos V, Golz JC, Stingl K, Kittler S, Seinige D, Kehrenberg C, Heimesaat MM, Bereswill S, Schulzke JD*, Bücker R (*corresponding) (2019) Curcumin mitigates immune-induced epithelial barrier dysfunction by Campylobacter jejuni. Int. J. Mol. Sci. 20(19): 4830 (19 pages) (IF 4.6) [PDF] [WebPage] [PDF]
Mousavi S, Lobo de Sá FD, Schulzke JD, Bücker R, Bereswill S, Heimesaat MM (2019) Vitamin D in acute campylobacteriosis ‒ results from an intervention study applying a clinical Campylobacter jejuni induced enterocolitis model. Front. Immunol. 10: 2094 (14 pages) (IF 5.1) [PubMed] [WebPage] [PDF]
Ebel H, Fromm A, Günzel D, Fromm M, Schulzke JD (2019) Phospholipid effects on SGLT1-mediated glucose transport in rabbit ileum brush border membrane vesicles. Biochim. Biophys. Acta - Biomembranes 1861(10): 182985 (pages 1-8) (IF 3.4) [PubMed] [WebPage] [PDF]
Harrer A, Bücker R, Boehm M, Zarzecka U, Tegtmeyer N, Sticht H, Schulzke JD, Backert S (2019) Campylobacter jejuni enters gut epithelial cells and impairs intestinal barrier function through cleavage of occludin by serine protease HtrA. Gut Pathog. 11: 4 (IF 3.3) [PubMed] [WebPage] [PDF]
Textbook chapter
Schulzke JD, Fromm M (2019) Chapter 14: "Magen-Darm-Trakt, Pankreas und Leber", in: Physiologie. Speckmann EJ, Hescheler J, Köhling R (eds.), 7. edn., Elsevier, München. ISBN 978-3-437-41358-2, eISBN 987-3-437-05844-8, p 549-588 [Publisher's ad] [Textbook of Physiology]
2018 Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M,
Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD (2018) Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.
Mucosal Immunol. 11(2): 474-485 (IF 7.4) [PubMed]
[DOI] [PDF]
[Supplement1] [Supplement2]